Studying Gene Expression in Samples From Patients With Rhabdoid Tumors

计划入组 25 人 · 首次发布于 2012 年 3 月 14 日

A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors

计划入组 340 人 · 首次发布于 2024 年 8 月 20 日

The Effect of an RBAC Supplement (BRM4) on NAFLD

计划入组 23 人 · 首次发布于 2015 年 10 月 6 日

BRM-011

BRM-1420

BRM-423

SRM Entertainment

United States

SRM UNIVERSITY

India

BRIM BIOTECHNOLOGY, INC.

Taiwan

Kamari Pharma Secures $23 Million Series A to Advance First-in-Class TRPV3 Inhibitor for Rare Genetic Skin Diseases

Memory B Cells Reveal Blueprint for Nasal Vaccines That Could Stop Respiratory Infections at Their Entry Point

Foghorn Therapeutics Discontinues FHD-286 Development for AML, Prioritizes Other Programs